| 日付 |
時間 |
ソース |
タイトル |
|---|
| 2024/5/03 | 20:30 | GLOBE | Ocugen to Host Conference Call on Tuesday, May 14 at 8:30.. |
| 2024/5/02 | 20:15 | GLOBE | Ocugen Announces CSO to Present on Modifier Gene Therapy at.. |
| 2024/4/29 | 19:45 | GLOBE | Ocugen Announces OCU400—Modifier Gene Therapy—Phase 1/2 Data.. |
| 2024/4/26 | 22:05 | GLOBE | UPDATE -- Ocugen to Present on Modifier Gene Therapy.. |
| 2024/4/26 | 19:30 | GLOBE | Ocugen to Present on Modifier Gene Therapy Platform at.. |
| 2024/4/19 | 20:13 | GLOBE | Ocugen Announces Dosing Completion of Subjects with.. |
| 2024/4/12 | 20:30 | GLOBE | Ocugen to Participate in Fireside Chat at the Emerging.. |
| 2024/4/10 | 20:02 | GLOBE | Ocugen, Inc. Announces Positive Scientific Advice from the.. |
| 2024/4/08 | 19:30 | GLOBE | Ocugen, Inc. Announces U.S. FDA Clearance of IND Amendment.. |
| 2024/4/05 | 20:02 | GLOBE | Ocugen Announces Positive Data and Safety Monitoring Board.. |
| 2024/4/02 | 21:00 | GLOBE | Ocugen Provides Business Update with Certain Financials for.. |
| 2024/4/02 | 07:08 | GLOBE | Ocugen Announces Positive Data and Safety Monitoring Board.. |
| 2024/4/02 | 06:43 | GLOBE | Ocugen to Host Conference Call on Tuesday, April 2 at 8:30.. |
| 2024/3/18 | 19:30 | GLOBE | Ocugen, Inc. Appoints Huma Qamar, MD, MPH as Chief Medical.. |
| 2024/3/13 | 21:00 | GLOBE | Ocugen, Inc. Announces Dosing Completion of Subjects with.. |
| 2024/3/06 | 21:30 | GLOBE | Ocugen to Present at Investing in Cures Summit |
| 2024/2/28 | 22:00 | GLOBE | Ocugen Clinical Showcase Webcast Now Available |
| 2024/2/26 | 22:30 | GLOBE | Ocugen Chairman and CEO to present at Abu Dhabi Family.. |
| 2024/2/23 | 06:05 | GLOBE | Ocugen, Inc. Announces Dosing Completion of Subjects with.. |
| 2024/2/22 | 06:05 | GLOBE | Ocugen to Present at 2024 BIO CEO & Investor Conference |
| 2024/2/22 | 01:22 | EDGAR2 | Form 8-K - Current report |
| 2024/2/14 | 21:30 | GLOBE | Ocugen to Host Clinical Showcase in New York City.. |
| 2024/1/31 | 22:00 | GLOBE | Ocugen to Present at Pharma Market Research Conference |
| 2024/1/16 | 21:30 | GLOBE | Ocugen, Inc. Announces Bob Smith Joins Business Advisory.. |
| 2024/1/08 | 20:05 | EDGAR2 | Form 8-K - Current report |
| 2024/1/06 | 06:47 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 2024/1/06 | 06:47 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 2024/1/05 | 07:05 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 2024/1/05 | 07:04 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 2023/12/23 | 05:09 | EDGAR2 | Form 8-K - Current report |
| 2023/12/21 | 20:30 | GLOBE | Ocugen Gains FDA Alignment on Key Aspects of OCU400—Modifier.. |
| 2023/12/19 | 21:30 | GLOBE | Ocugen Announces OCU400 Receives Regenerative Medicine.. |
| 2023/12/13 | 21:30 | GLOBE | Ocugen, Inc. Announces First Patient Dosed in Phase 1/2.. |
| 2023/11/29 | 21:30 | GLOBE | Ocugen CEO to Present at NobleCon19 – Noble Capital Markets’.. |
| 2023/11/10 | 21:30 | GLOBE | Ocugen, Inc. Announces First Patient Dosed in Phase 1/2.. |
| 2023/11/09 | 22:02 | EDGAR2 | Form 8-K - Current report |
| 2023/11/09 | 21:02 | EDGAR2 | Form 8-K - Current report |
| 2023/11/09 | 20:30 | GLOBE | Ocugen Provides Business Update with Third Quarter 2023.. |
| 2023/11/09 | 20:05 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 2023/11/07 | 21:45 | GLOBE | Ocugen CSO to Participate in 4th Annual Dry AMD Therapeutic.. |
| 2023/11/02 | 20:30 | GLOBE | Ocugen to Host Conference Call on Thursday, November 9 at.. |
| 2023/10/10 | 22:05 | EDGAR2 | Form 8-K - Current report |
| 2023/10/10 | 19:30 | GLOBE | Ocugen Mucosal Vaccine Candidate OCU500 Selected by.. |
| 2023/10/04 | 20:00 | GLOBE | Ocugen to Present at the 2023 Cell & Gene Meeting on the.. |
| 2023/9/29 | 20:30 | GLOBE | Ocugen CSO to Participate in 4th Annual Gene Therapy for.. |
| 2023/9/28 | 08:30 | GLOBE | Ocugen to Participate in Fireside Chat at Chardan’s 7th.. |
| 2023/9/21 | 20:30 | GLOBE | Ocugen, Inc. Announces Connie Collingsworth Joins Business.. |
| 2023/9/20 | 21:00 | GLOBE | Ocugen to Participate in Panel at Cantor Fitzgerald Global.. |
| 2023/9/20 | 05:54 | EDGAR2 | Form 8-K - Current report |
| 2023/9/20 | 05:01 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
Hot Features
プレミアム
登録してリアルタイムのチャート、分析ツール、価格を入手してください。
